Post-exposure prophylaxis against rabies at two newly designated intradermal rabies vaccination clinics in Kerala, India

National Medical Journal of India

Volumn 25, Issue 5, 2012, Pages 268-270

  Teena, M J ^a   Mathew, T ^a   Anish, T S ^a   Sujina, C M ^a   Philip, R R ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOG BITE; FEMALE; HEALTH CARE FACILITY; HELP SEEKING BEHAVIOR; HUMAN; INDIA; INFANT; INFECTION RISK; LACERATION; LEG INJURY; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; POST EXPOSURE PROPHYLAXIS; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RABIES; RISK ASSESSMENT; RURAL POPULATION; SEMI STRUCTURED INTERVIEW; VACCINATION; WOUND CARE; WOUND INFECTION;

ADOLESCENT; ADULT; ANIMALS; BITES AND STINGS; CATS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DOGS; FEMALE; HUMANS; INDIA; INFANT; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POST-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES; RURAL POPULATION; YOUNG ADULT;

EID: 84874207043     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. World Health Organization. WHO expert consultation on rabies. First report. WHO Technical Report Series No. 931. Geneva:WHO, 2005. Available at http:// www.who.int/rabies/trs931_%2006_05.pdf (accessed on 5 Aug 2011).
2. Jackson AC. Update on rabies diagnosis and treatment. Curr Infect Dis Rep 2009;11:296-301.
3. Sabchareon A, Chantavanich P, Pasuralertsakul S, Pojjaroen-Anant C, Prarinyanupharb V, Attanath P, et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J 1998;17:1001-7.
4. Beran J, Honegr K, Banzhoff A, Malerczyk C. Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: Investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine. Vaccine 2005;23:3902-7. Epub 2005 Apr 6.
5. Madhusudana SN, Sanjay TV, Mahendra BJ, Suja MS. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Int J Infect Dis 2004;8:175-9.
6. Sampath G, Madhusudana SN, Sudarshan MK, Ashwathnarayana DH, Mahendra BJ, Ullas TP, et al. Immunogenicity and safety study of Indirab: A Vero cell based chromatographically purified human rabies vaccine. Vaccine 2010;28:4086-90.
7. Mathew T. Implementation of IDRV in Kerala: A sustainable model. APCRI J 2010;12:42-3. Available at http://rabies.org.in/rabies/wp-content/uploads/2011/ 06/July2010.pdf (accessed on 5 Aug 2011).
8. Shetty RA, Chaturvedi S, Singh Z. Profile of animal bite cases in Pune. J Commun Dis 2005;37:66-72.
9. Sudarshan MK, Mahendra BJ, Madhusudana SN, Ashwoath Narayana DH, Rahman A, et al. An epidemiological study of animal bites in India: Results of a WHO sponsored national multi-centric rabies survey. J Commun Dis 2006;38:32-9.
10. Ichhpujani RL, Mala C, Veena M, Singh J, Bhardwaj M, Bhattacharya D, et al. Epidemiology of animal bites and rabies cases in India. A multicentric study. J Commun Dis 2008;40:27-36.
11. Sudarshan MK, Madhusudana SN, Mahendra BJ, Rao NS, Ashwath Narayana DH, Abdul Rahman S, et al. Assessing the burden of human rabies in India: Results of a national multi-center epidemiological survey. Int J Infect Dis 2007;11:29-35. Epub 2006 May 4.